Welcome to the July/August 2026 issue of Regulatory Rapporteur which focuses on therapeutics.

This issue explores how regulatory strategies are shaped by the unique demands of different therapeutic areas. From oncology, rare diseases and paediatrics to influenza, fertility and vaccine safety, we examine the evolving pathways, challenges and opportunities facing product development. Together, these articles highlight the critical role regulatory professionals play in navigating complex and often divergent requirements to support innovation and deliver safe, effective therapies to patients worldwide.